SML2932
Dexamethasone palmitate
≥98% (HPLC), corticosteroid prodrug, powder
别名:
(11β,16α)-9-Fluoro-11,17-dihydroxy-16-methyl-21-[(1-oxohexadecyl)oxy]pregna-1,4-diene-3,20-dione, Dexamethasone 21-palmitate
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C38H59FO6
化学文摘社编号:
分子量:
630.87
NACRES:
NA.77
UNSPSC Code:
51111800
MDL number:
产品名称
Dexamethasone palmitate, ≥98% (HPLC)
InChI key
WDPYZTKOEFDTCU-WDJQFAPHSA-N
SMILES string
O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@@]([C@](C(COC(CCCCCCCCCCCCCCC)=O)=O)(O)[C@H](C)C4)(C)[C@]4([H])[C@]3([H])CCC2=C1
InChI
1S/C38H59FO6/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-34(43)45-26-33(42)38(44)27(2)23-31-30-20-19-28-24-29(40)21-22-35(28,3)37(30,39)32(41)25-36(31,38)4/h21-22,24,27,30-32,41,44H,5-20,23,25-26H2,1-4H3/t27-,30+,31+,32+,35+,36+,37+,38+/m1/s1
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
−20°C
Quality Level
Biochem/physiol Actions
Dexamethasone Palmitate is a lipophilic prodrug of a potent corticosteroid dexamethasone that is quickly taking up by macrophages via phagocytosis. Dexamethasone Palmitate inhibits function and migration of leukocytes and tissue macrophages.
lipophilic prodrug of a potent corticosteroid dexamethasone
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
涉药品监管产品
此项目有
Satoshi Nishiwaki et al.
PloS one, 9(5), e96252-e96252 (2014-05-09)
Macrophage infiltration of skin GVHD lesions correlates directly with disease severity, but the mechanisms underlying this relationship remain unclear and GVHD with many macrophages is a therapeutic challenge. Here, we characterize the macrophages involved in GVHD and report that dexamethasone
Mathilde Lorscheider et al.
Journal of controlled release : official journal of the Controlled Release Society, 296, 179-189 (2019-01-20)
Rheumatoid arthritis (RA) is a prevalent autoimmune disease characterized by joint inflammation, bone and cartilage erosion. The use of glucocorticoids in the treatment of RA is hampered by significant side effects induced by their unfavorable pharmacokinetics. Delivering glucocorticoids by means
Mathilde Lorscheider et al.
Molecular pharmaceutics, 16(7), 2999-3010 (2019-05-24)
The encapsulation of glucocorticoids, such as dexamethasone, in nanoparticles (NPs) faces two main issues: a low drug loading and the destabilization of the nanoparticle suspension due to drug crystallization. Here, we successfully formulated a prodrug of dexamethasone, dexamethasone palmitate (DXP)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持